サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
市場調査レポート
商品コード
1764964

欧州の末梢塞栓用コイルの2031年市場予測-地域別分析-タイプ、材料、用途別

Europe Peripheral Embolization Coils Market Forecast to 2031 - Regional Analysis - by Type, Material, and Application

出版日
ページ情報
英文 117 Pages
納期
即納可能 即納可能とは
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=150.05円
欧州の末梢塞栓用コイルの2031年市場予測-地域別分析-タイプ、材料、用途別
出版日: 2025年04月14日
発行: The Insight Partners
ページ情報: 英文 117 Pages
納期: 即納可能 即納可能とは
GIIご利用のメリット
  • 全表示
  • 概要
  • 図表
  • 目次
概要

欧州の末梢塞栓用コイル市場は、2023年に1億8,947万米ドルと評価され、2031年には2億6,844万米ドルに達すると予測され、2023～2031年のCAGRは4.5%と推定されます。

がん発生率の増加が欧州の末梢塞栓用コイル市場を牽引

大腸がん、前立腺がん、肺がん、子宮頸がんは最も一般的ながんタイプです。世界保健機関（WHO）によると、2022年には2,000万人の新規がん患者と970万人のがん関連死亡者が報告されました。さらに、約5,300万人のがん患者が診断後5年間の生存率を示しました。ほぼ5人に1人が一生のうちにがんに罹患し、男性の9人に1人、女性の12人に1人ががんで死亡しています。同供給源によると、2050年までに新たに発生するがん患者は3,500万人に達し、2022年に報告された患者数から77％増加すると推定されています。コイル塞栓術は、塞栓コイルが腫瘍や組織異常への血液の流れを遮断したり止めたりするため、肺がん、肝臓がん、神経内分泌腫瘍、腎臓がん、子宮頸がんなどの治療に広く用いられています。脱着式塞栓コイルと押出可能な塞栓コイルはどちらも血管を塞いだり閉じたりするのに使用できます。プッシャブルコイルは、出血の抑制、動脈瘤や動静脈瘻などの血管病変の閉塞、非標的血管を保護するための血流の再分配など、さまざまな適応のために動脈や静脈で使用される機械的塞栓剤です。コイルによる塞栓術は、動脈瘤や腫瘍の成長を防ぎ、重要な臓器に害を及ぼすのを緩和するのに役立ちます。したがって、がん患者の増加により、末梢塞栓用コイルの需要が高まっています。

欧州の末梢塞栓用コイル市場概要

欧州の末梢塞栓用コイル市場は、ドイツ、英国、フランス、イタリア、スペイン、その他の欧州のに区分されます。欧州のは世界の末梢塞栓用コイル市場において重要な位置を占めており、予測期間中に力強い成長率を記録することが期待されています。同地域の市場成長は、主に大腸がんと消化管出血の急増に起因しています。GLOBOCAN 2020によると、ドイツでは2020年に57,528例（女性26,654例、男性30,874例を含む）の結腸直腸がんが新たに発生し、これらの症例のほぼ8例に1例は臨床評価で大腸（結腸）または直腸にがんの増殖が認められます。米国国立衛生ラボ（NIH）が発表した紙製によると、急性消化管出血（AGIB）は一般的な外科的問題であり、英国では年間8万5,000件、すなわち6分に1件の割合で発生しています。下部消化管出血（LGIB）の年間発生率は1万人あたり87人と推定されています。このような患者の全死亡率は入院患者で3.4％から17.8％です。現在、急性で生命を脅かすLGIBの治療において、内視鏡的アプローチが不可能または無効であることが判明した場合の初期段階として、塞栓術が提唱されています。脱着式コイル（3軸システムの有無は問わない）や液体塞栓剤は、他の塞栓剤よりも有効であることが証明されています。

下肢静脈瘤（膨らみ、過充満した静脈）は女性に多く、特に妊娠中や65歳以上の女性に多いです。Statistaによると、2020年にはスペインの65～74歳の女性50万人以上が静脈瘤と診断されています。静脈瘤塞栓術は外来治療で、最小限の回復時間ですみます。その際、皮膚（通常は鼠径部）に小さな傷をつけます。金属コイルをカテーテルに入れてから、静脈瘤の静脈内に誘導します。これにより、損傷した静脈を効果的に閉鎖し、血流を健康な静脈を通るによるルートで循環系に戻します。その他の欧州の諸国には、ポーランド、オーストリア、スイス、スウェーデン、ノルウェー、アイルランド、デンマーク、ベルギー、オランダなどの発展途上国が含まれます。Global Cancer Observatoryのデータによれば、2020年にベルギーで新たに診断された大腸がん患者は合計9,585人で、そのうち女性が4,150人、男性が5,435人です。さらに、ノルウェーでは2020年に約4,976例が新たに大腸がんと診断されました。スイスでは、2020年に約4,569例が新たに大腸がんと診断されます。大腸がんの一般的な合併症のひとつにGIBがあり、これは典型的には原発腫瘍のびらんや出血に関連しています。マイクロコイル塞栓術はGIBを減少させる有効な方法です。プッシャブルコイルは上部と下部消化管出血の両方に使用される最も一般的な塞栓剤です。

欧州の末梢塞栓用コイル市場の収益と2031年までの予測（金額）

欧州の末梢塞栓用コイルの市場セグメンテーション

欧州の末梢塞栓用コイル市場は、タイプ、材料、用途、国に分類されます。

タイプ別では、欧州の末梢塞栓用コイル市場は着脱式コイルとプッシャブルコイルに二分されます。2023年には着脱式コイルセグメントがより大きな市場シェアを占めています。

材料別では、欧州の末梢塞栓用コイル市場はプラチナ、プラチナ&ハイドロゲル、プラチナタングステン合金に分類されます。2023年にはプラチナセグメントが最大の市場シェアを占めています。

用途別では、欧州の末梢塞栓用コイル市場は出血・外傷、奇形、腫瘍、内臓動脈瘤、エンドリークII型、静脈瘤に区分されます。出血＆外傷セグメントが2023年に最大の市場シェアを占めました。

国別に見ると、欧州の末梢塞栓用コイル市場は、英国、ドイツ、フランス、イタリア、スペイン、その他の欧州のに区分されます。2023年の欧州の末梢塞栓用コイル市場シェアはドイツが独占しています。

Medtronic Plc、Penumbra, Inc.、Balt、Boston Scientific Corp、Cook Medical Holdings LLC、Wallaby Medical、Spartan Micro Inc.、Terumo Corp.などは、欧州の末梢塞栓用コイル市場で事業を展開する主要企業です。

目次

第1章 イントロダクション

第2章 エグゼクティブサマリー

  • 主要な洞察
  • 市場の魅力

第3章 調査手法

  • 二次調査
  • 一次調査
    • 仮説の策定
    • マクロ経済要因分析
    • ファンデーション数値の開発
    • データの三角測量
    • 国レベルのデータ

第4章 欧州の末梢塞栓用コイル市場：主要市場力学

  • 市場促進要因
    • 大動脈瘤の有病率の上昇
    • がんの発生率の増加
  • 市場抑制要因
    • 塞栓術の実施中または実施後に発生する合併症
  • 市場機会
    • 塞栓用コイルの応用範囲の拡大
  • 今後の動向
    • 充填密度の重要性の高まり
  • 促進要因と抑制要因の影響

第5章 末梢塞栓用コイル市場：欧州の分析

  • 欧州の末梢塞栓用コイル市場概要
  • 末梢塞栓用コイルの市場収益（2021～2031年）
  • 末梢塞栓用コイルの市場予測分析
  • 末梢塞栓用コイル市場企業のポジショニング

第6章 欧州の末梢塞栓用コイルの市場分析-製品タイプ別

  • イントロダクション
  • 着脱式コイル
  • プッシャブルコイル

第7章 欧州の末梢塞栓用コイルの市場分析-材料別

  • イントロダクション
  • プラチナ
  • プラチナ＆ハイドロゲル
  • 白金タングステン合金

第8章 欧州の末梢塞栓用コイルの市場分析-用途別

  • イントロダクション
  • 出血・外傷
  • 奇形
  • 腫瘍
  • 内臓動脈瘤
  • エンドリークII型
  • 静脈瘤

第9章 欧州の末梢塞栓用コイル市場：国別分析

  • 欧州
    • ドイツ
    • 英国
    • フランス
    • イタリア
    • スペイン
    • その他の欧州

第10章 末梢塞栓用コイル市場-産業情勢

  • イントロダクション
  • 末梢塞栓用コイル市場における成長戦略
  • 無機的成長戦略
    • 無機的成長戦略
  • 有機的成長戦略

第11章 企業プロファイル

  • Medtronic Plc
  • Penumbra, Inc.
  • Balt
  • Boston Scientific Corp
  • Cook Medical Holdings LLC
  • Wallaby Medical
  • Spartan Micro Inc.
  • Terumo Corp

第12章 付録

図表

List Of Tables

  • Table 1. Europe Peripheral Embolization Coils Market Segmentation
  • Table 2. Peripheral Embolization Coils Market - Revenue and Forecast to 2031 (US$ Million)
  • Table 3. Germany: Peripheral Embolization Coils Market - Revenue and Forecast to 2031 (US$ Million) - by Product Type
  • Table 4. Germany: Peripheral Embolization Coils Market - Revenue and Forecast to 2031 (US$ Million) - by Material
  • Table 5. Germany: Peripheral Embolization Coils Market - Revenue and Forecast to 2031 (US$ Million) - by Application
  • Table 6. United Kingdom: Peripheral Embolization Coils Market - Revenue and Forecast to 2031 (US$ Million) - by Product Type
  • Table 7. United Kingdom: Peripheral Embolization Coils Market - Revenue and Forecast to 2031 (US$ Million) - by Material
  • Table 8. United Kingdom: Peripheral Embolization Coils Market - Revenue and Forecast to 2031 (US$ Million) - by Application
  • Table 9. France: Peripheral Embolization Coils Market - Revenue and Forecast to 2031 (US$ Million) - by Product Type
  • Table 10. France: Peripheral Embolization Coils Market - Revenue and Forecast to 2031 (US$ Million) - by Material
  • Table 11. France: Peripheral Embolization Coils Market - Revenue and Forecast to 2031 (US$ Million) - by Application
  • Table 12. Italy: Peripheral Embolization Coils Market - Revenue and Forecast to 2031 (US$ Million) - by Product Type
  • Table 13. Italy: Peripheral Embolization Coils Market - Revenue and Forecast to 2031 (US$ Million) - by Material
  • Table 14. Italy: Peripheral Embolization Coils Market - Revenue and Forecast to 2031 (US$ Million) - by Application
  • Table 15. Spain: Peripheral Embolization Coils Market - Revenue and Forecast to 2031 (US$ Million) - by Product Type
  • Table 16. Spain: Peripheral Embolization Coils Market - Revenue and Forecast to 2031 (US$ Million) - by Material
  • Table 17. Spain: Peripheral Embolization Coils Market - Revenue and Forecast to 2031 (US$ Million) - by Application
  • Table 18. Rest of Europe: Peripheral Embolization Coils Market - Revenue and Forecast to 2031 (US$ Million) - by Product Type
  • Table 19. Rest of Europe: Peripheral Embolization Coils Market - Revenue and Forecast to 2031 (US$ Million) - by Material
  • Table 20. Rest of Europe: Peripheral Embolization Coils Market - Revenue and Forecast to 2031 (US$ Million) - by Application
  • Table 21. Recent Inorganic Growth Strategies in the Peripheral Embolization Coils Market
  • Table 22. Recent Organic Growth Strategies in the Peripheral Embolization Coils Market
  • Table 23. Glossary of Terms, Peripheral Embolization Coils Market

List Of Figures

  • Figure 1. Europe Peripheral Embolization Coils Market Segmentation, by Country
  • Figure 2. Peripheral Embolization Coils Market - Key Market Dynamics
  • Figure 3. Impact Analysis of Drivers and Restraints
  • Figure 4. Peripheral Embolization Coils Market Revenue (US$ Million), 2021-2031
  • Figure 5. Company Positioning
  • Figure 6. Peripheral Embolization Coils Market Share (%) - by Product Type (2023 and 2031)
  • Figure 7. Detachable Coil: Peripheral Embolization Coils Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 8. Pushable Coil: Peripheral Embolization Coils Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 9. Peripheral Embolization Coils Market Share (%) - by Material (2023 and 2031)
  • Figure 10. Platinum: Peripheral Embolization Coils Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 11. Platinum & Hydrogel: Peripheral Embolization Coils Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 12. Platinum Tungsten Alloy: Peripheral Embolization Coils Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 13. Peripheral Embolization Coils Market Share (%) - by Application (2023 and 2031)
  • Figure 14. Bleedings & Trauma: Peripheral Embolization Coils Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 15. Malformations: Peripheral Embolization Coils Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 16. Tumors: Peripheral Embolization Coils Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 17. Visceral Aneurysms: Peripheral Embolization Coils Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 18. Endoleak Type II: Peripheral Embolization Coils Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 19. Varicose Veins: Peripheral Embolization Coils Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 20. Europe: Peripheral Embolization Coils Market, by Key Country - Revenue (2023) (US$ Million)
  • Figure 21. Europe: Peripheral Embolization Coils Market Breakdown, by Key Countries, 2023 and 2031 (%)
  • Figure 22. Germany: Peripheral Embolization Coils Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 23. United Kingdom: Peripheral Embolization Coils Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 24. France: Peripheral Embolization Coils Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 25. Italy: Peripheral Embolization Coils Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 26. Spain: Peripheral Embolization Coils Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 27. Rest of Europe: Peripheral Embolization Coils Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 28. Growth Strategies in the Peripheral Embolization Coils Market
目次
Product Code: BMIRE00031511

The Europe peripheral embolization coils market was valued at US$ 189.47 million in 2023 and is expected to reach US$ 268.44 million by 2031; it is estimated to register a CAGR of 4.5% from 2023 to 2031.

Increase in Incidence of Cancer Drives Europe Peripheral Embolization Coils Market

Colorectal, prostate, lung, and cervical cancer are the most common types of cancer. According to the World Health Organization (WHO), ~20 million new cancer cases and 9.7 million cancer-related fatalities were reported in 2022. Moreover, approximately 53 million cancer patients exhibited a five-year survival rate after diagnosis. Nearly 1 in 5 people develop cancer in their lifetime; 1 in 9 men and 1 in 12 women die due to cancer. According to the same source, new cancer cases are estimated to reach the count of ~35 million by 2050, with a 77% increase from the number of cases reported in 2022. The coil embolization technique is widely used to treat patients suffering from lung cancer, liver cancer, neuroendocrine tumors, renal cancer, and cervical cancer, as the embolization coil blocks or stops the flow of blood to a tumor or tissue abnormality. Both detachable and pushable embolizing coils can be used to fill or close blood vessels. The pushable coils are mechanical embolic agents used in arteries and veins for various indications, including controlling bleeding, occluding vascular lesions such as aneurysms and arteriovenous fistulas, and redistributing blood flow to protect non-target vessels. Embolization with coils helps prevent the growth of aneurysms and tumors, thus mitigating their ability to harm essential organs. Thus, the rising prevalence of cancer cases creates a high demand for peripheral embolization coils.

Europe Peripheral Embolization Coils Market Overview

The Europe peripheral embolization coils market is further segmented into Germany, the UK, France, Italy, Spain, and the Rest of Europe. Europe occupies a significant position in the global peripheral embolization coils market and is expected to record a strong growth rate during the forecast period. The market growth in the region is mainly attributed to the burgeoning cases of colorectal cancer and gastrointestinal bleeding. According to GLOBOCAN 2020, Germany recorded ~57,528 new colorectal cases (including 26,654 women and 30,874 men) in 2020; nearly one in eight of these cases show cancerous growth in the large intestine (colon) or rectum in clinical evaluation. According to an article released by the National Institutes of Health (NIH), acute gastrointestinal bleeding (AGIB) is a prevalent surgical problem, accounting for ~85,000 occurrences per year in the UK, i.e., 1 case every 6 minutes. The lower gastrointestinal bleeding (LGIB) has an estimated annual incidence of 87 per 10,000 persons. The overall mortality rate for such patients varies from 3.4% to 17.8% for inpatients. Embolization is currently advocated as the initial step in the treatment of acute, life-threatening LGIB when an endoscopic approach proves to be impossible or ineffective. Detachable coils (with or without a triaxial system), as well as liquid embolic agents, have proven to be more effective than other embolic agents.

Varicose veins (bulging, overfilled veins) are highly common among women, particularly during pregnancy and in women over the age of 65. According to Statista, more than 500,000 women aged 65-74 in Spain were diagnosed with varicose veins in 2020. Varicocele embolization is an outpatient treatment that requires minimal recovery time. During the process, a small nick is made in the skin (typically in the groin). Metal coils are put into the catheter before being guided into the varicocele's varicose veins. This effectively closes up the damaged veins and redirects blood flow back to the circulatory system via a different route through healthy veins. Rest of Europe includes developing countries such as Poland, Austria, Switzerland, Sweden, Norway, Ireland, Denmark, Belgium, and the Netherlands. As per the Global Cancer Observatory data, a total of 9,585 new colorectal cancer cases were diagnosed in Belgium in 2020, including 4,150 cases in women and 5,435 in men. Further, nearly 4,976 new colorectal cancer cases in Norway were diagnosed in 2020. In Switzerland, approximately 4,569 new colorectal cancer cases were diagnosed in 2020. One of the common complications of colorectal cancer is GIB, which is typically related to primary tumor erosion and hemorrhage. Microcoil embolization is an effective method for decreasing GIB. Pushable coils are the most common embolic agent utilized in both upper and lower gastrointestinal hemorrhage.

Europe Peripheral Embolization Coils Market Revenue and Forecast to 2031 (US$ Million)

Europe Peripheral Embolization Coils Market Segmentation

The Europe peripheral embolization coils market is categorized into type, material, application, and country.

Based on type, the Europe peripheral embolization coils market is bifurcated into detachable coil and pushable coil. The detachable coil segment held a larger market share in 2023.

In terms of material, the Europe peripheral embolization coils market is categorized into platinum, platinum & hydrogel, and platinum tungsten alloy. The platinum segment held the largest market share in 2023.

By application, the Europe peripheral embolization coils market is segmented into bleedings & trauma, malformations, tumours, visceral aneurysm, endoleak type II, and varicose veins. The bleedings & trauma segment held the largest market share in 2023.

Based on country, the Europe peripheral embolization coils market is segmented into the UK, Germany, France, Italy, Spain, and the Rest of Europe. Germany dominated the Europe peripheral embolization coils market share in 2023.

Medtronic Plc; Penumbra, Inc.; Balt; Boston Scientific Corp; Cook Medical Holdings LLC; Wallaby Medical; Spartan Micro Inc.; and Terumo Corp. are some of the leading companies operating in the Europe peripheral embolization coils market.

Table Of Contents

1. Introduction

  • 1.1 The Insight Partners Research Report Guidance
  • 1.2 Market Segmentation

2. Executive Summary

  • 2.1 Key Insights
  • 2.2 Market Attractiveness

3. Research Methodology

  • 3.1 Secondary Research
  • 3.2 Primary Research
    • 3.2.1 Hypothesis formulation:
    • 3.2.2 Macro-economic factor analysis:
    • 3.2.3 Developing base number:
    • 3.2.4 Data Triangulation:
    • 3.2.5 Country level data:

4. Europe Peripheral Embolization Coils Market - Key Market Dynamics

  • 4.1 Market Drivers
    • 4.1.1 Rise in Prevalence of Aortic Aneurysm
    • 4.1.2 Increase in Incidence of Cancer
  • 4.2 Market Restraints
    • 4.2.1 Complications Arising During or After Embolization
  • 4.3 Market Opportunities
    • 4.3.1 Expanding Range of Applications of Embolization Coils
  • 4.4 Future Trends
    • 4.4.1 Growing Importance of Packing Density
  • 4.5 Impact of Drivers and Restraints:

5. Peripheral Embolization Coils Market - Europe Analysis

  • 5.1 Europe Peripheral Embolization Coils Market Overview
  • 5.2 Peripheral Embolization Coils Market Revenue (US$ Million), 2021-2031
  • 5.3 Peripheral Embolization Coils Market Forecast Analysis
  • 5.4 Peripheral Embolization Coils Market: Company Positioning

6. Europe Peripheral Embolization Coils Market Analysis - by Product Type

  • 6.1 Overview
  • 6.2 Detachable Coil
    • 6.2.1 Overview
    • 6.2.2 Detachable Coil: Peripheral Embolization Coils Market - Revenue and Forecast to 2031 (US$ Million)
  • 6.3 Pushable Coil
    • 6.3.1 Overview
    • 6.3.2 Pushable Coil: Peripheral Embolization Coils Market - Revenue and Forecast to 2031 (US$ Million)

7. Europe Peripheral Embolization Coils Market Analysis - by Material

  • 7.1 Overview
  • 7.2 Platinum
    • 7.2.1 Overview
    • 7.2.2 Platinum: Peripheral Embolization Coils Market - Revenue and Forecast to 2031 (US$ Million)
  • 7.3 Platinum & Hydrogel
    • 7.3.1 Overview
    • 7.3.2 Platinum & Hydrogel: Peripheral Embolization Coils Market - Revenue and Forecast to 2031 (US$ Million)
  • 7.4 Platinum Tungsten Alloy
    • 7.4.1 Overview
    • 7.4.2 Platinum Tungsten Alloy: Peripheral Embolization Coils Market - Revenue and Forecast to 2031 (US$ Million)

8. Europe Peripheral Embolization Coils Market Analysis - by Application

  • 8.1 Overview
  • 8.2 Bleedings & Trauma
    • 8.2.1 Overview
    • 8.2.2 Bleedings & Trauma: Peripheral Embolization Coils Market - Revenue and Forecast to 2031 (US$ Million)
  • 8.3 Malformations
    • 8.3.1 Overview
    • 8.3.2 Malformations: Peripheral Embolization Coils Market - Revenue and Forecast to 2031 (US$ Million)
  • 8.4 Tumors
    • 8.4.1 Overview
    • 8.4.2 Tumors: Peripheral Embolization Coils Market - Revenue and Forecast to 2031 (US$ Million)
  • 8.5 Visceral Aneurysms
    • 8.5.1 Overview
    • 8.5.2 Visceral Aneurysms: Peripheral Embolization Coils Market - Revenue and Forecast to 2031 (US$ Million)
  • 8.6 Endoleak Type II
    • 8.6.1 Overview
    • 8.6.2 Endoleak Type II: Peripheral Embolization Coils Market - Revenue and Forecast to 2031 (US$ Million)
  • 8.7 Varicose Veins
    • 8.7.1 Overview
    • 8.7.2 Varicose Veins: Peripheral Embolization Coils Market - Revenue and Forecast to 2031 (US$ Million)

9. Europe Peripheral Embolization Coils Market - Country Analysis

  • 9.1 Europe: Market Overview
    • 9.1.1 Europe: Peripheral Embolization Coils Market Breakdown, by Key Country, 2023 and 2031 (%)
      • 9.1.1.1 Germany: Peripheral Embolization Coils Market - Revenue and Forecast to 2031 (US$ Million)
        • 9.1.1.1.1 Germany: Peripheral Embolization Coils Market Breakdown, by Product Type
        • 9.1.1.1.2 Germany: Peripheral Embolization Coils Market Breakdown, by Material
        • 9.1.1.1.3 Germany: Peripheral Embolization Coils Market Breakdown, by Application
      • 9.1.1.2 United Kingdom: Peripheral Embolization Coils Market - Revenue and Forecast to 2031 (US$ Million)
        • 9.1.1.2.1 United Kingdom: Peripheral Embolization Coils Market Breakdown, by Product Type
        • 9.1.1.2.2 United Kingdom: Peripheral Embolization Coils Market Breakdown, by Material
        • 9.1.1.2.3 United Kingdom: Peripheral Embolization Coils Market Breakdown, by Application
      • 9.1.1.3 France: Peripheral Embolization Coils Market - Revenue and Forecast to 2031 (US$ Million)
        • 9.1.1.3.1 France: Peripheral Embolization Coils Market Breakdown, by Product Type
        • 9.1.1.3.2 France: Peripheral Embolization Coils Market Breakdown, by Material
        • 9.1.1.3.3 France: Peripheral Embolization Coils Market Breakdown, by Application
      • 9.1.1.4 Italy: Peripheral Embolization Coils Market - Revenue and Forecast to 2031 (US$ Million)
        • 9.1.1.4.1 Italy: Peripheral Embolization Coils Market Breakdown, by Product Type
        • 9.1.1.4.2 Italy: Peripheral Embolization Coils Market Breakdown, by Material
        • 9.1.1.4.3 Italy: Peripheral Embolization Coils Market Breakdown, by Application
      • 9.1.1.5 Spain: Peripheral Embolization Coils Market - Revenue and Forecast to 2031 (US$ Million)
        • 9.1.1.5.1 Spain: Peripheral Embolization Coils Market Breakdown, by Product Type
        • 9.1.1.5.2 Spain: Peripheral Embolization Coils Market Breakdown, by Material
        • 9.1.1.5.3 Spain: Peripheral Embolization Coils Market Breakdown, by Application
      • 9.1.1.6 Rest of Europe: Peripheral Embolization Coils Market - Revenue and Forecast to 2031 (US$ Million)
        • 9.1.1.6.1 Rest of Europe: Peripheral Embolization Coils Market Breakdown, by Product Type
        • 9.1.1.6.2 Rest of Europe: Peripheral Embolization Coils Market Breakdown, by Material
        • 9.1.1.6.3 Rest of Europe: Peripheral Embolization Coils Market Breakdown, by Application

10. Peripheral Embolization Coils Market-Industry Landscape

  • 10.1 Overview
  • 10.2 Growth Strategies in the Peripheral Embolization Coils Market
  • 10.3 Inorganic Growth Strategies
    • 10.3.1 Overview
  • 10.4 Organic Growth Strategies
    • 10.4.1 Overview

11. Company Profiles

  • 11.1 Medtronic Plc
    • 11.1.1 Key Facts
    • 11.1.2 Business Description
    • 11.1.3 Products and Services
    • 11.1.4 Financial Overview
    • 11.1.5 SWOT Analysis
    • 11.1.6 Key Developments
  • 11.2 Penumbra, Inc.
    • 11.2.1 Key Facts
    • 11.2.2 Business Description
    • 11.2.3 Products and Services
    • 11.2.4 Financial Overview
    • 11.2.5 SWOT Analysis
    • 11.2.6 Key Developments
  • 11.3 Balt
    • 11.3.1 Key Facts
    • 11.3.2 Business Description
    • 11.3.3 Products and Services
    • 11.3.4 Financial Overview
    • 11.3.5 SWOT Analysis
    • 11.3.6 Key Developments
  • 11.4 Boston Scientific Corp
    • 11.4.1 Key Facts
    • 11.4.2 Business Description
    • 11.4.3 Products and Services
    • 11.4.4 Financial Overview
    • 11.4.5 SWOT Analysis
    • 11.4.6 Key Developments
  • 11.5 Cook Medical Holdings LLC
    • 11.5.1 Key Facts
    • 11.5.2 Business Description
    • 11.5.3 Products and Services
    • 11.5.4 Financial Overview
    • 11.5.5 SWOT Analysis
    • 11.5.6 Key Developments
  • 11.6 Wallaby Medical
    • 11.6.1 Key Facts
    • 11.6.2 Business Description
    • 11.6.3 Products and Services
    • 11.6.4 Financial Overview
    • 11.6.5 SWOT Analysis
    • 11.6.6 Key Developments
  • 11.7 Spartan Micro Inc.
    • 11.7.1 Key Facts
    • 11.7.2 Business Description
    • 11.7.3 Products and Services
    • 11.7.4 Financial Overview
    • 11.7.5 SWOT Analysis
    • 11.7.6 Key Developments
  • 11.8 Terumo Corp
    • 11.8.1 Key Facts
    • 11.8.2 Business Description
    • 11.8.3 Products and Services
    • 11.8.4 Financial Overview
    • 11.8.5 SWOT Analysis
    • 11.8.6 Key Developments

12. Appendix

  • 12.1 About The Insight Partners
  • 12.2 Glossary of Terms